Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Finished Goods (2017 - 2023)

Historic Finished Goods for Perspective Therapeutics (CATX) over the last 11 years, with Q3 2023 value amounting to $20000.0.

  • Perspective Therapeutics' Finished Goods fell 2592.59% to $20000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $20000.0, marking a year-over-year decrease of 2592.59%. This contributed to the annual value of $21000.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Perspective Therapeutics reported Finished Goods of $20000.0 as of Q3 2023, which was down 2592.59% from $18000.0 recorded in Q2 2023.
  • In the past 5 years, Perspective Therapeutics' Finished Goods ranged from a high of $49000.0 in Q2 2021 and a low of $7000.0 during Q4 2019
  • For the 5-year period, Perspective Therapeutics' Finished Goods averaged around $22368.4, with its median value being $21000.0 (2022).
  • Per our database at Business Quant, Perspective Therapeutics' Finished Goods tumbled by 7297.3% in 2019 and then surged by 31428.57% in 2021.
  • Over the past 5 years, Perspective Therapeutics' Finished Goods (Quarter) stood at $7000.0 in 2019, then changed by 0.0% to $7000.0 in 2020, then soared by 314.29% to $29000.0 in 2021, then decreased by 27.59% to $21000.0 in 2022, then dropped by 4.76% to $20000.0 in 2023.
  • Its Finished Goods was $20000.0 in Q3 2023, compared to $18000.0 in Q2 2023 and $15000.0 in Q1 2023.